Natural History and Prevention of Viral Hepatitis Among Alaska Natives (CDC-RFA-PS-13-001)

Period Length: 5 years

This cooperative agreement supports efforts to improve the health of Alaska Native persons disproportionately affected by hepatitis including researching viral hepatitis outcomes and effectiveness. The project has two principal aims: 1) to improve efforts to prevent hepatitis A and B through vaccination and 2) to study interventions to reduce illness and deaths among people living with hepatitis B and hepatitis C.

CDC has awarded funding to one institution in Anchorage, AK: Alaska Native Tribal Health Consortium

Funding:

Funding for the fifth (and final) year of the project is expected to be approximately $131,522.